Do you qualify for compensation? Find Out Now (30-second survey)

Taxotere Tied to Permanent Hair Loss

Taxotere and Permanent Alopecia – What They Knew, When They Knew It

When you were told that you or a loved one had breast cancer, you undoubtedly found it painful to cope with this devastating news. More than likely, you lacked the desire or strength to research Taxotere (docetaxel), other chemotherapy options, and the potential adverse effects that these drugs could cause. After all, don’t our doctors, the pharmaceutical companies and the FDA know how best to treat medical conditions? Unfortunately, we don’t always know the whole truth until it’s too late.

What They Knew

Taxotere (docetaxel) is a synthetic chemotherapy drug that was introduced to the market in January 2005 by Sanofi-Aventis to treat breast cancer. Unfortunately, women started reporting that after completing chemotherapy treatments, their hair wasn’t growing back. Some women had only wisps of hair, others had just a light fuzz and many were completely bald and didn’t even grow back their eyelashes or eyebrows.

In an article published in the American Journal of Dermatopathology, researchers discovered that six out of ten cancer patients who were diagnosed with permanent alopecia had taken Taxotere. Rocky Mountain Cancer Centers in Colorado stated that 6.3% of their breast cancer patients grew back less than 50% of their hair after taking Taxotere. In a report published by the Annals of Oncology, scientists proved that, “severe and permanent female hair loss, especially scalp alopecia, is a new and rare cutaneous side-effect of the sequential FEC–docetaxel regimen used for early breast cancer adjuvant treatment.”

When They Knew It

The problems is that Sanofi-Aventis knew that permanent alopecia was a significant risk to its users and warned patients in Europe and Canada. However, it was marketed in the U.S. without a warning FOR TEN YEARS before the FDA had a warning put out in December 2015 (and it was located on page 32 out of 64 pages! Who reads that!?!)

What Can You Do?

Sanofi-Aventis clearly disregarded study findings and patient complaints. They deliberately failed to warn U.S. patients of the risk of permanent alopecia. There are other chemotherapy medications available that do not pose the long term risk of permanent alopecia, but patients weren’t given the full disclosure to make the best choice. If you had breast cancer, were prescribed Taxotere (docetaxel) and were diagnosed with permanent hair loss, you may be able to make a claim. Not only did you suffer from having cancer, but now you are spending countless dollars on expensive wigs or on other products to help you manage this difficult situation. It’s not your fault that you have permanent alopecia and we want to help you to determine if you are able to receive financial compensation.

Taxotere Warnings In The News

BREAKING (6/27/18): 5 Taxotere Bellwether Trials Scheduled for May 2019

According to an Order made by the U.S. District Court, Eastern District of Louisiana, the first trial concerning Taxotere and its link to permanent alopecia (hair loss) is scheduled for May 13th – 24th, 2019. Four other trials addressing this same issue also have set court dates: September 16-27, 2019, January 27-February 7, 2020, May 11-22, 2020, and September 14-25, 2020. This is a huge step forward for those who took Taxotere for breast cancer and were never warned about the possibility of never again having a full head of hair.

Read Full Article

FDA Permanent Taxotere Label: Cases of Permanent Alopecia Have Been Reported

Filed Taxotere Complaints & Damages

12/7/17: Rita Alfred v. Sanofi-Aventis U.S. LLC, et al.
12/14/16: Burns et al v. v. Sanofi-Aventis U.S. LLC, et al.

GET YOUR FREE Taxotere CASE REVIEW TODAY

Taxotere settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Our in-house legal counsel, Matthew J. Daher, earned his Bachelor of Arts degree from the University of Utah and his law degree from the University of Missouri – Columbia School of Law. Matt has devoted his entire practice to civil litigation, and has spent his career representing the rights of individuals who have been injured by pharmaceuticals, medical devices, medical malpractice, defective products, and motor vehicle accidents. As in-house counsel for Periscope Group, Matt leads our internal legal team and liaises with our external partners.

Trademark Info: Taxotere® is a registered trademark of Sanofi-Aventis U.S. LLC and is used here for informational and product identification purposes only.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

LATEST ARTICLES

FDA Adverse Effect Reporting System and Why it Doesn’t Work

It can be really scary to take a medication and read about the possible dangerous side effects that could happen. However, many times there could be other frightening side effects or harmful drug interactions that weren’t made evident in the pre-market testing. This is why it’s important to report to the FDA if you’re experiencing problems that weren’t listed in the packet that came with your medication. However, reporting drug and device problems to the FDA isn’t an easy process and could be allowing potentially unsafe drugs and medical devices to put others in harm’s way.

(more…)

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification